Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Philadelphia positive acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Follicular lymphoma

Not recruiting

Investigational

Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Thrombotic microangiopathy

Not recruiting

Registered drug

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ravulizumab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Porphyria non-acute

Not recruiting

Investigational

Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dersimelagon Phosphate

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Adult T-cell lymphoma/leukaemia+2

Not recruiting

Registered drugNo placebo

Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Etoposide

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pirtobrutinib

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Find therapies in clinical trials near you – page 6

79 trials match your criteria

Philadelphia positive acute lymphocytic leukaemia

Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Follicular lymphoma

Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma

Plasma cell myeloma

Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

Thrombotic microangiopathy

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Malignant melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Porphyria non-acute

Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

Non-small cell lung cancer

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Adult T-cell lymphoma/leukaemia+2

Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

Chronic lymphocytic leukaemia

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Neoplasm malignant

Study on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors

Non-small cell lung cancer

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Acute myeloid leukaemia

Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.